Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and t...

Full description

Bibliographic Details
Main Authors: Martin, Natasha K, Vickerman, Peter, Grebely, Jason, Hellard, Margaret, Hutchinson, Sharon J, Lima, Viviane D, Foster, Graham R, Dillon, John F, Goldberg, David J, Dore, Gregory J, Hickman, Matthew
Format: Online
Language:English
Published: Blackwell publishing Ltd 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933734/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933734/

Similar Items